Back to search

United States· US:51662-1668_4ddcdfff-1469-bff0-e063-6294a90a5480

METHYLERGONOVINE MALEATE

A medicinal product containing methylergonovine maleate, registered in United States by HF Acquisition Co. LLC. DBA HealthFirst.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedMETHYLERGONOVINE MALEATEATC—REGISTER NO.US:51662-1668_4ddcdff…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
METHYLERGONOVINE MALEATE
Manufacturer
HF Acquisition Co. LLC. DBA HealthFirst
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    51662-1668-1
  • ndc11
    5166216681
    1 mL in 1 VIAL (51662-1668-1)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Methylergonovine maleate in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methylergonovine maleate products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Belgium · Methergin
  • Bulgaria · Methergin, Метергин
  • Germany · Methergin, Methergin®
  • Denmark · Methergin
  • Spain · Methergin, Methergín
  • France · Methergin
  • Greece · Demergin
  • Iceland · Methergin
  • Italy · Methergin
  • Luxembourg · Methergin
  • Netherlands · Methergin
  • Sweden · Methergin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/eb1dae3a-a6db-44ac-a231-1fd6fe6f5f5e
GET /v1/drugs/eb1dae3a-a6db-44ac-a231-1fd6fe6f5f5e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAMUSCULAR; INTRAVENOUS",
  "source": "ndc",
  "strength": ".2",
  "substance": "METHYLERGONOVINE MALEATE",
  "productndc": "51662-1668",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "ANDA090193",
  "marketing_category": "ANDA"
}

See everything about methylergonovine maleate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.